Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TJ004309 and Toripalimab in Advanced Solid Tumor
NCT04322006Phase 2Completed
- Sponsor
- TJ Biopharma
- Start
- May 2020
- Primary completion
- Apr 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of uliledlimab in solid tumor (advanced stage), sponsored by TJ Biopharma. Started May 2020; status: completed.
02
Drugs
uliledlimab
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT04322006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04322006.